CLIA lab

CLIA 01D2097849: Beauregard Drugs Inc

Opelika, AL. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 01D2097849 belongs to Beauregard Drugs Inc in Opelika, AL.

Certificate of Waiver, effective June 25, 2025, expires June 24, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
June 25, 2025
Certificate expiration
June 24, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
June 25, 2015
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
01D2097849
Lab name
Beauregard Drugs Inc
Address
7667 Al Hwy 51 Ste A, Opelika, AL 36804
Phone
(334) 364-9993
Fax
(334) 364-9997

Annual test volume the lab reported

Waived tests
500

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Opelika, AL

Related

Questions

What is the CLIA number for Beauregard Drugs Inc in Opelika?

01D2097849, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Beauregard Drugs Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 01D2097849 expire?

The CMS file lists June 24, 2027 as the certificate expiration date; the certificate took effect June 25, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.